Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

A Preview Of Collegium Pharmaceutical's Earnings

Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Collegium Pharmaceutical will report an earnings per share (EPS) of $0.90.

Benzinga

Earnings Preview: Cleanspark

Cleanspark (NASDAQ:CLSK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Cleanspark will report an earnings per share (EPS) of $0.30.

Benzinga

Earnings Preview For Purple Innovation

Purple Innovation (NASDAQ:PRPL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Purple Innovation will report an earnings per share (EPS) of $-0.35.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Where Akoya Biosciences Stands With Analysts

Akoya Biosciences (NASDAQ:AKYA) has observed the following analyst ratings within the last quarter:

Benzinga

This Is What Whales Are Betting On Trade Desk

Someone with a lot of money to spend has taken a bearish stance on Trade Desk (NASDAQ:TTD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

How Is The Market Feeling About AGNC Investment?

AGNC Investment's (NASDAQ:AGNC) short percent of float has risen 49.23% since its last report. The company recently reported that it has 24.95 million shares sold short, which is 4.82% of all regular shares that are available for trading.

Benzinga

Why Apple Shares Are Diving Today

Shares of several companies in the broader tech sector, including Apple Inc (NASDAQ: AAPL), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Otter Tail's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Otter Tail (NASDAQ:OTTR).

Benzinga

Tetra Tech's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Tetra Tech (NASDAQ:TTEK).

Benzinga

Why This Match Group Analyst Is Swiping Right

Match Group Inc (NASDAQ: MTCH) reported strong first-quarter results, despite headwinds.

Benzinga

SSR Mining: Dividend Insights

Wednesday marks the last chance for investors to receive the next dividend payout from SSR Mining (NASDAQ:SSRM).

Benzinga

Wednesday Is Your Last Chance To Buy Midland States Bancorp Before The Dividend Payout

Wednesday marks the last chance for investors to receive the next dividend payout from Midland States Bancorp (NASDAQ:MSBI).

Benzinga

Why Tesla Shares Are Diving Today

Shares of several companies in the auto & auto component space, including Tesla Inc (NASDAQ: TSLA), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

Benzinga

Tesla Refuses To Integrate Apple's CarPlay — You Can Do It Anyway

Apple Inc.'s (NASDAQ: AAPL) CarPlay car integration standard has seen no official support from Elon Musk's car manufacturer Tesla Inc. (NASDAQ: TSLA) despite it being a widely requested fea

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Look Into Communication Services Sector Value Stocks

The Meaning Behind Value Stocks

Benzinga

5 Value Stocks To Watch In The Healthcare Sector

What Defines a Value Stock?

Benzinga

5 Value Stocks In The Real Estate Sector

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

Insider Weekends: "Adjusted" Insider Buying Increased Last Week With Insiders Purchasing $176.54 Million Of Stock

During a highly volatile week for markets, we saw insiders step up and purchase shares, although in aggregate it looked like both insider buying and selling declined compared to the prior week.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On Qualcomm

Someone with a lot of money to spend has taken a bullish stance on Qualcomm (NASDAQ:QCOM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Plug Power Whale Trades For May 09

A whale with a lot of money to spend has taken a noticeably bearish stance on Plug Power. Looking at options history for Plug Power (NASDAQ:PLUG) we detected 19 strange trades.

Benzinga

Where BeiGene Stands With Analysts

Within the last quarter, BeiGene (NASDAQ:BGNE) has observed the following analyst ratings:

Benzinga

CH-Auto Challenges Li Auto, Nio, Xpeng with U.S. SPAC Listing

Key takeaways:

Benzinga

Achilles Therapeutics Doses First Patient with Higher-dose cNeT in CHIRON Phase 1/2a Trial for Advanced NSCLC

Achilles Therapeutics plc (NASDAQ: ACHL) announced that the first patient has been dosed with personalized clonal neoantigen-reactive T cells, or cNeT, manufactured with the Company's higher-dose VELOS™ Process 2 in the ongoing Phase I/IIa CHIRON clinical trial for the treatment of advanced non-small cell lung can

Benzinga

Why LogicBio Therapeutics Shares Are Popping Off Today

LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher by 63.48% at $0.81 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmaloni

Benzinga

Preview: comScore's Earnings

comScore (NASDAQ:SCOR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that comScore will report an earnings per share (EPS) of $-0.14.

1 … 600 601 602 603

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.